TABLE 4 Algorithm used to estimate distribution of post-RS treatment recommendations in N0 patients based on TAILORx results.
From: PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
Nodal status | Patient age | Treatment recommendations | |||
|---|---|---|---|---|---|
RS 0–15 | RS 16–20 | RS 21–25 | RS 26–100 | ||
N0 | ≤50 Years | HT-only | HT-only 90% | HT-only 60% | CT + HT |
CT + HT 10% | CT + HT 40% | ||||
>50 Years | HT-only | CT + HT | |||
